Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Cage Rattler who wrote (611)	10/21/1998 2:52:00 PM
From: mammoth	Read Replies (1) \| Respond to of 1255

At least it looks like CORX has support at these levels. Can't really go much lower. Any positive news re: success of human trials or partnering agreement should hopefully move it back up.

To: Cage Rattler who wrote (611)	10/21/1998 8:47:00 PM
From: DavidCG	Respond to of 1255

The medical community doesn't reveal results until data is published and it can be peer evaluated. Otherwise, there would be no need for medical journals. It's so simple... the Wake Forest University study was completed 3 times on rats to make sure they weren't getting false data. Once Wake Forest was convinced this was an excellent drug on rats, and they verified their own data three times... they published the results. NBC saw the results published and ran with it by interviewing the researcher at Wake Forest University. It's that simple. Once the phase of I/IIa human testing is completed... guess what.. data will be published again for peer evaluation in a medical journal NBC will pick up the story, and run with it again. Probably interviewing the National Institutes of Health. I think all the news agencies know better that it is better to be accurate with scientific data than look stupid on camera. Remember the genious news coverage of Cold-Fusion? When was the last time you saw a news story like that on national news? Not since. Once bitten, twice shy. -DavidCG

To: Cage Rattler who wrote (611)	10/21/1998 8:56:00 PM
From: DavidCG	Read Replies (2) \| Respond to of 1255

Isn't it interesting that NEOT is supposedly producing a wonder drug just ahead of CORX...yet there is no national news coverage. CORX has been on national news twice. I find that odd. Don't you? Could it be that NBC/ABC are squeemish to cover a drug that hasn't been tested by independent universities like CORX has? Or is being tested currently by the NIH? Could it be that NEOT's phase I testing was done in Canada and not the United States? It just seems odd that CORX with a market cap of $7 million gets the jump on NEOT with a market cap of $52 million for national news play. Instead of complaining that CORX didn't get the exact media coverage you wanted (sure, all of us investors WANTED a 1/2 hour Dateline exclusive)...you should be thinking: "Why isn't CORX's competition getting any national coverage whatsoever?" That's exactly what I was thinking when I bought this stock. Why should ABC/NBC care about a $1 - $4 stock? -DavidCG